Literature DB >> 18332794

Operative repair or endovascular stent graft in blunt traumatic thoracic aortic injuries: results of an American Association for the Surgery of Trauma Multicenter Study.

Demetrios Demetriades1, George C Velmahos, Thomas M Scalea, Gregory J Jurkovich, Riyad Karmy-Jones, Pedro G Teixeira, Mark R Hemmila, James V O'Connor, Mark O McKenney, Forrest O Moore, Jason London, Michael J Singh, Edward Lineen, Konstantinos Spaniolas, Marius Keel, Michael Sugrue, Wendy L Wahl, Jonathan Hill, Mathew J Wall, Ernest E Moore, Daniel Margulies, Valerie Malka, Linda S Chan.   

Abstract

INTRODUCTION: The purpose of this American Association for the Surgery of Trauma multicenter study is to assess the early efficacy and safety of endovascular stent grafts (SGs) in traumatic thoracic aortic injuries and compare outcomes with the standard operative repair (OR). PATIENTS: Prospective, multicenter study. Data for the following were collected: age, blood pressure, and Glasgow Coma Scale (GCS) at admission, type of aortic injury, injury severity score, abbreviate injury scale (AIS), transfusions, survival, ventilator days, complications, and intensive care unit and hospital days. The outcomes between the two groups (open repair or SG) were compared, adjusting for presence of critical extrathoracic trauma (head, abdomen, or extremity AIS >3), GCS score </=8, systolic blood pressure <90 mm Hg, and age >55 years. Separate multivariable analysis was performed, one for patients without and one for patients with associated critical extrathoracic injuries (head, abdomen, or extremity AIS >3), to compare the outcomes of the two therapeutic modalities adjusting for hypotension, GCS score </=8, and age >55 years.
RESULTS: One hundred ninety-three patients met the criteria for inclusion. Overall, 125 patients (64.9%) were selected for SG and 68 (35.2%) for OR. SG was selected in 71.6% of the 74 patients with major extrathoracic injuries and in 60.0% of the 115 patients with no major extrathoracic injuries. SG patients were significantly older than OR patients. Overall, 25 patients in the SG group (20.0%) developed 32 device-related complications. There were 18 endoleaks (14.4%), 6 of which needed open repair. Procedure-related paraplegia developed in 2.9% in the OR and 0.8% in the SG groups (p = 0.28). Multivariable analysis adjusting for severe extrathoracic injuries, hypotension, GCS, and age, showed that the SG group had a significantly lower mortality (adjusted odds ratio: 8.42; 95% CI: [2.76-25.69]; adjusted p value <0.001), and fewer blood transfusions (adjusted mean difference: 4.98; 95% CI: [0.14-9.82]; adjusted p value = 0.046) than the OR group. Among the 115 patients without major extrathoracic injuries, higher mortality and higher transfusion requirements were also found in the OR group (adjusted odds ratio for mortality: 13.08; 95% CI [2.53-67.53], adjusted p value = 0.002 and adjusted mean difference in transfusion units: 4.45; 95% CI [1.39-7.51]; adjusted p value = 0.004). Among the 74 patients with major extrathoracic injuries, significantly higher mortality and pneumonia rate were found in the OR group (adjusted p values 0.04 and 0.03, respectively). Multivariate analysis showed that centers with high volume of endovascular procedures had significantly fewer systemic complications (adjusted p value 0.001), fewer local complications (adjusted p value p = 0.033), and shorter hospital lengths of stay (adjusted p value 0.005) than low-volume centers.
CONCLUSIONS: Most surgeons select SG for traumatic thoracic aortic ruptures, irrespective of associated injuries, injury severity, and age. SG is associated with significantly lower mortality and fewer blood transfusions, but there is a considerable risk of serious device-related complications. There is a major and urgent need for improvement of the available endovascular devices.

Entities:  

Mesh:

Year:  2008        PMID: 18332794     DOI: 10.1097/TA.0b013e3181641bb3

Source DB:  PubMed          Journal:  J Trauma        ISSN: 0022-5282


  52 in total

Review 1.  TEVAR: Endovascular Repair of the Thoracic Aorta.

Authors:  David A Nation; Grace J Wang
Journal:  Semin Intervent Radiol       Date:  2015-09       Impact factor: 1.513

2.  Endovascular therapy in trauma.

Authors:  M Brenner; M Hoehn; T E Rasmussen
Journal:  Eur J Trauma Emerg Surg       Date:  2014-11-23       Impact factor: 3.693

3.  Endovascular repair of the thoracic aorta.

Authors:  Grace J Wang; Ronald M Fairman
Journal:  Semin Intervent Radiol       Date:  2009-03       Impact factor: 1.513

4.  Open and endovascular approaches to aortic trauma.

Authors:  Matthew J Wall; Peter I Tsai; Ramyar Gilani; Kenneth L Mattox
Journal:  Tex Heart Inst J       Date:  2010

5.  Blunt aortic injury: risk factors and impact of surgical approaches.

Authors:  Chien-Chao Lin; Kuo-Sheng Liu; Huan-Wu Chen; Yao-Kuang Huang; Jaw-Ji Chu; Feng-Chun Tsai; Pyng Jing Lin
Journal:  Surg Today       Date:  2015-04-07       Impact factor: 2.549

6.  Natural history of minimal aortic injury following blunt thoracic aortic trauma.

Authors:  Biniam Kidane; Daniel Abramowitz; Jeremy R Harris; Guy DeRose; Thomas L Forbes
Journal:  Can J Surg       Date:  2012-12       Impact factor: 2.089

7.  Endovascular stent grafts in urgent blunt and penetrating thoracic aortic trauma.

Authors:  Kenneth J Kolbeck; John A Kaufman
Journal:  Semin Intervent Radiol       Date:  2011-03       Impact factor: 1.513

8.  Traumatic aortic injuries associated with major visceral vascular injuries in major blunt trauma patients.

Authors:  Victor X Mosquera; Milagros Marini; Ignacio Cao; Daniel Gulías; Javier Muñiz; José M Herrera-Noreña; José J Cuenca
Journal:  World J Surg       Date:  2012-07       Impact factor: 3.352

9.  A review of endovascular treatment of thoracic aorta disease.

Authors:  Gjs Tan; Plz Khoo; Kmj Chan
Journal:  Ann R Coll Surg Engl       Date:  2018-10-05       Impact factor: 1.891

Review 10.  Vascular injuries after blunt chest trauma: diagnosis and management.

Authors:  James V O'Connor; Christopher Byrne; Thomas M Scalea; Bartley P Griffith; David G Neschis
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2009-09-14       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.